nodes	percent_of_prediction	percent_of_DWPC	metapath
Bifonazole—CYP17A1—Dexamethasone—multiple sclerosis	0.202	0.224	CbGbCtD
Bifonazole—CYP19A1—Betamethasone—multiple sclerosis	0.135	0.15	CbGbCtD
Bifonazole—CYP2E1—Fingolimod—multiple sclerosis	0.135	0.15	CbGbCtD
Bifonazole—CYP19A1—Dexamethasone—multiple sclerosis	0.0788	0.0874	CbGbCtD
Bifonazole—CYP2E1—Mitoxantrone—multiple sclerosis	0.0635	0.0705	CbGbCtD
Bifonazole—CYP3A4—Fingolimod—multiple sclerosis	0.0409	0.0454	CbGbCtD
Bifonazole—CYP2C19—Prednisone—multiple sclerosis	0.0331	0.0367	CbGbCtD
Bifonazole—CYP2E1—Dexamethasone—multiple sclerosis	0.0329	0.0365	CbGbCtD
Bifonazole—CYP2B6—Dexamethasone—multiple sclerosis	0.0325	0.0361	CbGbCtD
Bifonazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0264	0.0293	CbGbCtD
Bifonazole—CYP2C19—Dexamethasone—multiple sclerosis	0.0206	0.0229	CbGbCtD
Bifonazole—CYP3A4—Triamcinolone—multiple sclerosis	0.02	0.0222	CbGbCtD
Bifonazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0192	0.0214	CbGbCtD
Bifonazole—CYP3A4—Betamethasone—multiple sclerosis	0.0172	0.019	CbGbCtD
Bifonazole—CYP3A4—Prednisolone—multiple sclerosis	0.0169	0.0188	CbGbCtD
Bifonazole—CYP3A4—Prednisone—multiple sclerosis	0.016	0.0177	CbGbCtD
Bifonazole—CYP3A4—Dexamethasone—multiple sclerosis	0.00998	0.0111	CbGbCtD
Bifonazole—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00321	0.0325	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00321	0.0325	CbGpPWpGaD
Bifonazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00234	0.0237	CbGpPWpGaD
Bifonazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00234	0.0237	CbGpPWpGaD
Bifonazole—CYP51A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00231	0.0234	CbGpPWpGaD
Bifonazole—CYP51A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00231	0.0234	CbGpPWpGaD
Bifonazole—CYP17A1—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.00224	0.0227	CbGpPWpGaD
Bifonazole—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00199	0.0201	CbGpPWpGaD
Bifonazole—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00199	0.0201	CbGpPWpGaD
Bifonazole—CYP17A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00196	0.0199	CbGpPWpGaD
Bifonazole—CYP17A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00196	0.0199	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00194	0.0197	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00194	0.0197	CbGpPWpGaD
Bifonazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0019	0.0192	CbGpPWpGaD
Bifonazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0019	0.0192	CbGpPWpGaD
Bifonazole—CYP17A1—Androgen biosynthesis—POMC—multiple sclerosis	0.00174	0.0176	CbGpPWpGaD
Bifonazole—CYP17A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00161	0.0163	CbGpPWpGaD
Bifonazole—CYP17A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00161	0.0163	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00122	0.0123	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00122	0.0123	CbGpPWpGaD
Bifonazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0012	0.0122	CbGpPWpGaD
Bifonazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0012	0.0122	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00119	0.0121	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00119	0.0121	CbGpPWpGaD
Bifonazole—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00119	0.012	CbGpPWpGaD
Bifonazole—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00119	0.012	CbGpPWpGaD
Bifonazole—CYP51A1—Endogenous sterols—POMC—multiple sclerosis	0.00113	0.0115	CbGpPWpGaD
Bifonazole—CYP51A1—Biological oxidations—CYP27B1—multiple sclerosis	0.00101	0.0102	CbGpPWpGaD
Bifonazole—CYP51A1—Biological oxidations—CYP24A1—multiple sclerosis	0.00101	0.0102	CbGpPWpGaD
Bifonazole—CYP51A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000993	0.0101	CbGpPWpGaD
Bifonazole—CYP51A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000993	0.0101	CbGpPWpGaD
Bifonazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000977	0.00988	CbGpPWpGaD
Bifonazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000977	0.00988	CbGpPWpGaD
Bifonazole—CYP17A1—Endogenous sterols—POMC—multiple sclerosis	0.000963	0.00975	CbGpPWpGaD
Bifonazole—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000933	0.00944	CbGpPWpGaD
Bifonazole—CYP17A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000856	0.00867	CbGpPWpGaD
Bifonazole—CYP17A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000856	0.00867	CbGpPWpGaD
Bifonazole—CYP17A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000845	0.00855	CbGpPWpGaD
Bifonazole—CYP17A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000845	0.00855	CbGpPWpGaD
Bifonazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000774	0.00783	CbGpPWpGaD
Bifonazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000774	0.00783	CbGpPWpGaD
Bifonazole—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000764	0.00773	CbGpPWpGaD
Bifonazole—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000764	0.00773	CbGpPWpGaD
Bifonazole—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000761	0.0077	CbGpPWpGaD
Bifonazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000758	0.00767	CbGpPWpGaD
Bifonazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000758	0.00767	CbGpPWpGaD
Bifonazole—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000748	0.00757	CbGpPWpGaD
Bifonazole—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000748	0.00757	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000722	0.0073	CbGpPWpGaD
Bifonazole—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000652	0.0066	CbGpPWpGaD
Bifonazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000627	0.00635	CbGpPWpGaD
Bifonazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000627	0.00635	CbGpPWpGaD
Bifonazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000614	0.00622	CbGpPWpGaD
Bifonazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000614	0.00622	CbGpPWpGaD
Bifonazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000585	0.00592	CbGpPWpGaD
Bifonazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000585	0.00592	CbGpPWpGaD
Bifonazole—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000584	0.00591	CbGpPWpGaD
Bifonazole—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000577	0.00584	CbGpPWpGaD
Bifonazole—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000577	0.00584	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000554	0.00561	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000554	0.00561	CbGpPWpGaD
Bifonazole—CYP51A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000526	0.00532	CbGpPWpGaD
Bifonazole—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000519	0.00525	CbGpPWpGaD
Bifonazole—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000519	0.00525	CbGpPWpGaD
Bifonazole—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000512	0.00518	CbGpPWpGaD
Bifonazole—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000512	0.00518	CbGpPWpGaD
Bifonazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.00049	0.00496	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.00049	0.00495	CbGpPWpGaD
Bifonazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000474	0.0048	CbGpPWpGaD
Bifonazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000474	0.0048	CbGpPWpGaD
Bifonazole—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000447	0.00453	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000437	0.00443	CbGpPWpGaD
Bifonazole—CYP51A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000426	0.00432	CbGpPWpGaD
Bifonazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000399	0.00404	CbGpPWpGaD
Bifonazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000391	0.00395	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000387	0.00391	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000387	0.00391	CbGpPWpGaD
Bifonazole—CYP17A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000363	0.00367	CbGpPWpGaD
Bifonazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000352	0.00356	CbGpPWpGaD
Bifonazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000352	0.00356	CbGpPWpGaD
Bifonazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000347	0.00351	CbGpPWpGaD
Bifonazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000347	0.00351	CbGpPWpGaD
Bifonazole—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000333	0.00337	CbGpPWpGaD
Bifonazole—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000333	0.00337	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000329	0.00333	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000329	0.00333	CbGpPWpGaD
Bifonazole—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000329	0.00333	CbGpPWpGaD
Bifonazole—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000329	0.00333	CbGpPWpGaD
Bifonazole—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000326	0.0033	CbGpPWpGaD
Bifonazole—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000326	0.0033	CbGpPWpGaD
Bifonazole—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000322	0.00326	CbGpPWpGaD
Bifonazole—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000322	0.00326	CbGpPWpGaD
Bifonazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000315	0.00319	CbGpPWpGaD
Bifonazole—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.00029	0.00294	CbGpPWpGaD
Bifonazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000285	0.00288	CbGpPWpGaD
Bifonazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000285	0.00288	CbGpPWpGaD
Bifonazole—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000274	0.00277	CbGpPWpGaD
Bifonazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000271	0.00274	CbGpPWpGaD
Bifonazole—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000252	0.00255	CbGpPWpGaD
Bifonazole—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000252	0.00255	CbGpPWpGaD
Bifonazole—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000248	0.00251	CbGpPWpGaD
Bifonazole—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000248	0.00251	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—SRM—multiple sclerosis	0.000244	0.00247	CbGpPWpGaD
Bifonazole—CYP51A1—Biological oxidations—POMC—multiple sclerosis	0.000227	0.00229	CbGpPWpGaD
Bifonazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00022	0.00222	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—SRM—multiple sclerosis	0.000208	0.0021	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000199	0.00202	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000199	0.00202	CbGpPWpGaD
Bifonazole—CYP17A1—Biological oxidations—POMC—multiple sclerosis	0.000193	0.00195	CbGpPWpGaD
Bifonazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000181	0.00183	CbGpPWpGaD
Bifonazole—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000174	0.00176	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—CYP27B1—multiple sclerosis	0.000172	0.00174	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—CYP24A1—multiple sclerosis	0.000172	0.00174	CbGpPWpGaD
Bifonazole—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00017	0.00173	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000168	0.0017	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—GPC5—multiple sclerosis	0.000158	0.00159	CbGpPWpGaD
Bifonazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000151	0.00153	CbGpPWpGaD
Bifonazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000151	0.00153	CbGpPWpGaD
Bifonazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000149	0.00151	CbGpPWpGaD
Bifonazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000149	0.00151	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—CYP24A1—multiple sclerosis	0.000146	0.00148	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—CYP27B1—multiple sclerosis	0.000146	0.00148	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000143	0.00145	CbGpPWpGaD
Bifonazole—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000141	0.00143	CbGpPWpGaD
Bifonazole—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000138	0.0014	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—GPC5—multiple sclerosis	0.000134	0.00136	CbGpPWpGaD
Bifonazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000132	0.00133	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—RRM1—multiple sclerosis	0.000131	0.00132	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—SRM—multiple sclerosis	0.000126	0.00127	CbGpPWpGaD
Bifonazole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000126	0.00127	CbGpPWpGaD
Bifonazole—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000117	0.00118	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—RRM1—multiple sclerosis	0.000111	0.00112	CbGpPWpGaD
Bifonazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000107	0.00108	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000101	0.00102	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.67e-05	0.000978	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.67e-05	0.000978	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	8.87e-05	0.000898	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	8.87e-05	0.000898	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.7e-05	0.00088	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.67e-05	0.000878	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.61e-05	0.000871	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—GPC5—multiple sclerosis	8.11e-05	0.000821	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—SRM—multiple sclerosis	8.09e-05	0.000818	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.93e-05	0.000803	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—SRM—multiple sclerosis	7.92e-05	0.000802	CbGpPWpGaD
Bifonazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.91e-05	0.0008	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—BCHE—multiple sclerosis	7.5e-05	0.000759	CbGpPWpGaD
Bifonazole—CYP2B6—Biological oxidations—POMC—multiple sclerosis	7.5e-05	0.000759	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	7.49e-05	0.000758	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.4e-05	0.000749	CbGpPWpGaD
Bifonazole—CYP2E1—Biological oxidations—POMC—multiple sclerosis	7.34e-05	0.000743	CbGpPWpGaD
Bifonazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	7.32e-05	0.000741	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.74e-05	0.000683	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—RRM1—multiple sclerosis	6.72e-05	0.000681	CbGpPWpGaD
Bifonazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.41e-05	0.000649	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—BCHE—multiple sclerosis	6.37e-05	0.000645	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—SRM—multiple sclerosis	6.11e-05	0.000619	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.7e-05	0.000577	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.7e-05	0.000577	CbGpPWpGaD
Bifonazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	5.66e-05	0.000573	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	5.58e-05	0.000565	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	5.58e-05	0.000565	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.22e-05	0.000528	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—GPC5—multiple sclerosis	5.21e-05	0.000527	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—GPC5—multiple sclerosis	5.1e-05	0.000517	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—APOE—multiple sclerosis	4.51e-05	0.000456	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.48e-05	0.000454	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.32e-05	0.000437	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.31e-05	0.000436	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.31e-05	0.000436	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.23e-05	0.000428	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.21e-05	0.000426	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.09e-05	0.000414	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.94e-05	0.000399	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—POMC—multiple sclerosis	3.87e-05	0.000392	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—BCHE—multiple sclerosis	3.86e-05	0.000391	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—APOE—multiple sclerosis	3.83e-05	0.000388	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000372	CbGpPWpGaD
Bifonazole—CYP51A1—Metabolism—ALB—multiple sclerosis	3.53e-05	0.000357	CbGpPWpGaD
Bifonazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.000345	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—POMC—multiple sclerosis	3.29e-05	0.000333	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.26e-05	0.00033	CbGpPWpGaD
Bifonazole—CYP17A1—Metabolism—ALB—multiple sclerosis	3e-05	0.000304	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.000262	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.000262	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.53e-05	0.000256	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.48e-05	0.000251	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.43e-05	0.000246	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.00024	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—APOE—multiple sclerosis	2.32e-05	0.000235	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.17e-05	0.00022	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—POMC—multiple sclerosis	2e-05	0.000202	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.98e-05	0.000201	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.000199	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.87e-05	0.00019	CbGpPWpGaD
Bifonazole—CYP19A1—Metabolism—ALB—multiple sclerosis	1.82e-05	0.000184	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—APOE—multiple sclerosis	1.49e-05	0.000151	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—APOE—multiple sclerosis	1.46e-05	0.000148	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—POMC—multiple sclerosis	1.28e-05	0.00013	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—POMC—multiple sclerosis	1.26e-05	0.000127	CbGpPWpGaD
Bifonazole—CYP2B6—Metabolism—ALB—multiple sclerosis	1.17e-05	0.000118	CbGpPWpGaD
Bifonazole—CYP2E1—Metabolism—ALB—multiple sclerosis	1.14e-05	0.000116	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—APOE—multiple sclerosis	1.13e-05	0.000114	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000114	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—POMC—multiple sclerosis	9.69e-06	9.8e-05	CbGpPWpGaD
Bifonazole—CYP2C19—Metabolism—ALB—multiple sclerosis	8.83e-06	8.94e-05	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—APOE—multiple sclerosis	6.78e-06	6.86e-05	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—POMC—multiple sclerosis	5.82e-06	5.89e-05	CbGpPWpGaD
Bifonazole—CYP3A4—Metabolism—ALB—multiple sclerosis	5.31e-06	5.37e-05	CbGpPWpGaD
